Results 231 to 240 of about 448,470 (384)

Rheumatology: A Primary Care Approach. First edition. Bruce M. Rothschild MD. New Yorke Medical Books, 1982. 416 pages. Illustrated [PDF]

, 1983
William A. Norcross
openalex   +1 more source

CONTRACTING IN RHEUMATOLOGY [PDF]

Rheumatology, 1992
openaire   +5 more sources

Rheumatology in Lithuania [PDF]

Rheumatology, 1997
A Venalis, Irena Butrimiene
openaire   +2 more sources

Differences in Dynamics of Specific Antinuclear Antibodies and Their Susceptibility to B Cell–Targeting Treatment in Patients With Systemic Lupus Erythematosus

Arthritis &Rheumatology, EarlyView.
Objective The presence of antinuclear antibodies (ANAs) is characteristic for systemic lupus erythematosus (SLE). Antibody dynamics over time are thought to reflect the cellular source of ANAs and their therapeutic targetability. Anti–double‐stranded DNA (anti‐dsDNA) is the most prevalent and well‐studied of all ANAs, and fluctuations in anti‐dsDNA ...
Hugo J. van Dooren, Mieke van Schaik, Annemarie L. Dorjée, Eline J. Arends, Meggan Mackay, Laura Cooney, David A. Fox, David Wofsy, Dawn Smilek, Cynthia Aranow, Maria Dall'Era, Tom W. J. Huizinga, Cees van Kooten, René E. M. Toes, Betty Diamond, Y. K. Onno Teng, Jolien Suurmond   +16 more
wiley   +1 more source

Supplementum 279: Abstracts of the annual meeting of the Swiss Society of Rheumatology

Swiss Medical Weekly
Swiss Society of Rheumatology
doaj   +1 more source

Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE survey. [PDF]

Ther Adv Musculoskelet Dis
Schreiber K, Graversgaard C, Parodis I, Agmon-Levin N, Aguilera S, Antovic A, Bertsias GK, Bini I, Bobirca A, Capela S, Cervera R, Costedoat-Chalumeau N, Dolhain R, Etomi O, Flint J, Fonseca JE, Fritsch-Stork R, Förger F, Giles I, Goulden B, Götestam Skorpen C, Gunnarsson I, Gupta L, Koksvik HS, Linde L, Lykke J, Meissner Y, Molto A, Moore L, Mosca M, Nelson-Piercy C, Perez-Garcia LF, Raio L, Rom AL, Rottenstreich A, Saleh M, Sciascia S, Strangfeld A, Svenungsson E, Tektonidou MG, Tincani A, Troldborg A, Vojinovic J, Voss A, Wallenius M, Zuniga-Serrano N, Andreoli L.   +46 more
europepmc   +1 more source

Announcements: International Symposium on Pediatric Rheumatology Paris, July 21–22,1989 [PDF]

, 1988

openalex   +1 more source

Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid‐Dependent Polymyalgia Rheumatica

Arthritis &Rheumatology, EarlyView.
Objective The SEMAPHORE trial evaluated the efficacy and safety of tocilizumab (TCZ) treatment in patients with glucocorticoid (GC)‐dependent polymyalgia rheumatica (PMR). TCZ reduced GC dose and disease activity at week 24. This study aimed to assess relapse rates after stopping TCZ treatment in patients achieving remission at week 24.
Baptiste Chevet, Aghiles Souki, Emmanuel Nowak, Guillermo Carvajal‐Alegria, Emmanuelle Dernis, Christophe Richez, Marie‐Elise Truchetet, Daniel Wendling, Eric Toussirot, Aleth Perdriger, Jacques‐Eric Gottenberg, Renaud Felten, Bruno Fautrel, Anne Lohse, Laurent Chiche, Pascal Hilliquin, Catherine Le Henaff, Benjamin Dervieux, Guillaume Direz, Isabelle Chary‐Valckenaere, Divi Cornec, Dewi Guellec, Thierry Marhadour, Alain Saraux, Valérie Devauchelle‐Pensec   +24 more
wiley   +1 more source

Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019

, 2020
Bathon, J., Breedveld, F., Burmester, G., Bykerk, V., Crofford, L., Cronstein, B., Dougados, M., Furst, D., Kalden, J., Mariette, X., Mease, P., Melchers, F., Rosenbaum, J., Sieper, J., Smolen, J., Weinblatt, M., Winthrop, K.   +16 more
core   +1 more source

Digital empowerment on hold: DiGA adoption gaps-a German national cross-sectional patient survey study. [PDF]

Rheumatol Int
Kremer P, Fink D, Morf H, Labinsky H, Gente K, Aries P, Krusche M, Muehlensiepen F, Kuhn S, Hueber A, Knitza J.   +10 more
europepmc   +1 more source